Resolve Biosciences
the German company (Monheim am Rhein) commercialises the Molecular Cartography platform — an in-situ-sequencing, padlock-probe-based targeted spatial-transcriptomics system cited alongside CosMx and Xenium as one of the commercial imaging-based platforms (Nature Methods, 2025).
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Spatial transcriptomics & spatial multi-omics | bioinformatics-omics | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.